JOHNSON & JOHNSON
JOHNSON & JOHNSON
Share · US4781601046 · JNJ · 853260 (XNYS)
Overview Financial Indicators
155,51 USD
1,30 % 2,00 USD
NYSE (XNYS) · Current prices and charts at MoneyPeak
06.06.2025 22:28

Current Prices from JOHNSON & JOHNSON

ExchangeTickerCurrencyLast TradePriceDaily Change
XNYS: NYSE
NYSE
JNJ
USD
06.06.2025 22:28
155,51 USD
153,66 USD
+1,20 %
XETR: XETRA
XETRA
JNJ.DE
EUR
06.06.2025 15:35
135,84 EUR
134,30 EUR
+1,15 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 0,08 % 0,67 % -6,22 % 4,38 % 5,20 % 5,57 %

Company Profile for JOHNSON & JOHNSON Share

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Invested Funds

The following funds have invested in: JOHNSON & JOHNSON invested:

Fund
iShares MSCI USA Islamic UCITS ETF USD (Dist)
Vol. in million
11.885,14
Percentage (%)
7,11 %
Fund
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. in million
21.456,84
Percentage (%)
5,88 %
Fund
iShares MSCI World Quality Dividend UCITS ETF USD (Acc)
Vol. in million
1.867,23
Percentage (%)
3,92 %
Fund
iShares MSCI World Islamic UCITS ETF USD (Dist)
Vol. in million
12.780,82
Percentage (%)
3,89 %
Fund
iShares Dow Jones Industrial Average UCITS ETF (DE)
Vol. in million
8.737,62
Percentage (%)
3,24 %

Company Data

Name JOHNSON & JOHNSON
Company Johnson & Johnson
Symbol JNJ
Website https://www.jnj.com
Primary Exchange XNYS NYSE
WKN 853260
ISIN US4781601046
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Mr. Joaquin Duato
Market Capitalization 334 Mrd.
Country United States of America
Currency USD
Employees 138,1 T
Address One Johnson & Johnson Plaza, 08933 New Brunswick
IPO Date 2007-12-28
Dividends from 'JOHNSON & JOHNSON'
Ex-Date Dividend per Share
27.05.2025 1,30 USD
18.02.2025 1,24 USD
26.11.2024 1,24 USD
27.08.2024 1,24 USD
20.05.2024 1,24 USD
16.02.2024 1,19 USD
20.11.2023 1,19 USD
25.08.2023 1,19 USD
22.05.2023 1,19 USD
17.02.2023 1,13 USD

Stock Splits

Date Split
13.06.2001 2:1
12.06.1996 2:1
10.06.1992 2:1
11.05.1989 2:1
19.05.1981 3:1
18.05.1970 3:1
19.06.1967 3:1

Ticker Symbols

Name Symbol
Frankfurt JNJ.F
NYSE JNJ
XETRA JNJ.DE

More Shares

Investors who JOHNSON & JOHNSON hold also have the following shares in their portfolio:
ALLIANZ AG
ALLIANZ AG Share
AMAZON.CO INC
AMAZON.CO INC Share
APPLE INC
APPLE INC Share
COCA-COLA CO
COCA-COLA CO Share
FINLAB AG
FINLAB AG Share
FOCUS GRAPHITE INC
FOCUS GRAPHITE INC Share
INVESCO EXCHANGE-TRADED FUND TRUST - INVESCO DWA CONSUMER STAPLES MOMENTUM ETF
INVESCO EXCHANGE-TRADED FUND TRUST - INVESCO DWA CONSUMER STAPLES MOMENTUM ETF ETF
LDSBK.SAAR OPF A423
LDSBK.SAAR OPF A423 Bond
MCDONALDS CORP
MCDONALDS CORP Share
MICROSOFT CORP
MICROSOFT CORP Share
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Share
TESLA INC
TESLA INC Share
UNILEVER PLC
UNILEVER PLC Share
VISA INC - CLASS A
VISA INC - CLASS A Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025